Integrative Practitioner's top articles of 2022

FDA seeks to ban compounded glutathione, AANP responds with call-to-action

Access to compounded glutathione is under review by the U.S. Food and Drug Administration (FDA) and the committee that advises the agency on this matter will meet on June 8 to discuss whether to continue to allow glutathione to be compounded.

Read more here